[HTML] mdpi.com

[HTML][HTML] Novel gene signatures predictive of patient recurrence-free survival and castration resistance in prostate cancer

B Zhang, Z Zhang, H Hu, JT Dong - Cancers, 2021 - mdpi.com
Simple Summary Molecular signatures predictive of recurrence-free survival (RFS) and
castration resistance are critical for treatment decision-making in prostate cancer (PCa), but …
被引用次数：24 相关文章
[HTML] nih.gov

[HTML][HTML] Novel Gene Signatures Predictive of Patient Recurrence-Free Survival and Castration Resistance in Prostate Cancer

A Jun, B Zhang, Z Zhang, H Hu, JT Dong - Cancers, 2021 - ncbi.nlm.nih.gov
Molecular signatures predictive of recurrence-free survival (RFS) and castration resistance
are critical for treatment decision-making in prostate cancer (PCa), but the robustness of …

Novel Gene Signatures Predictive of Patient Recurrence-Free Survival and Castration Resistance in Prostate Cancer.

B Zhang, Z Zhang, H Hu, JT Dong, YE Whang - Cancers, 2021 - search.ebscohost.com
Abstract Simple Summary: Molecular signatures predictive of recurrence-free survival (RFS)
and castration resistance are critical for treatment decision-making in prostate cancer (PCa) …

Novel Gene Signatures Predictive of Patient Recurrence-Free Survival and Castration Resistance in Prostate Cancer.

B Zhang, Z Zhang, H Hu, JT Dong - Cancers, 2021 - europepmc.org
Molecular signatures predictive of recurrence-free survival (RFS) and castration resistance
are critical for treatment decision-making in prostate cancer (PCa), but the robustness of …

Novel Gene Signatures Predictive of Patient Recurrence-Free Survival and Castration Resistance in Prostate Cancer

A Jun, B Zhang, Z Zhang, H Hu, JT Dong - Cancers, 2021 - pubmed.ncbi.nlm.nih.gov
Molecular signatures predictive of recurrence-free survival (RFS) and castration resistance
are critical for treatment decision-making in prostate cancer (PCa), but the robustness of …